This topic contains a solution. Click here to go to the answer

Author Question: Patients receiving immune serums should be evaluated for what action of the serums? 1. Headaches ... (Read 52 times)

Mr. Wonderful

  • Hero Member
  • *****
  • Posts: 866
Patients receiving immune serums should be evaluated for what action of the serums?
 
  1. Headaches
  2. Skin rash
  3. Disease suppression
  4. Numbness in the fingers

Question 2

A 25-year-old patient believed that he still had natural immunity from childhood illnesses until he developed chickenpox. How will the nurse explain this situation to the patient?
 
  1. He never had an injection for immunity.
  2. Artificially-acquired active immunity doesn't always confer lifelong immunity.
  3. He never got a booster as a child.
  4. There was no immunity injection for this disease.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

InfiniteSteez

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

3
Patients receiving immune serums should be evaluated for suppression of the disease.

Answer to Question 2

2
Some early immunizations lose their ability to provide long-term immunity.




Mr. Wonderful

  • Member
  • Posts: 866
Reply 2 on: Jul 23, 2018
Excellent


xthemafja

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Gracias!

 

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library